Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-10-02

Clinical Trial Update: MA-CEAL Community Health Ambassador Program [NA]

View source ↗

Summary

Boston Medical Center has withdrawn the MA-CEAL Community Health Ambassador Program trial (NCT07136402). The study targeted hypertension and diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Boston Medical Center | Conditions: Hypertension, Diabetes Mellitus | NA | Status: WITHDRAWN